Germany-based Boehringer Ingelheim has entered into a five-year research and health care innovation collaboration with US-based health system, Sutter Health.

As part of the collaboration, the organizations will explore and test the value of digital health solutions, mobile technologies and insights from advanced data analytics in the delivery of health care.

Initially, the firms will focus on developing solutions for chronic obstructive pulmonary disease (COPD), in a bid to make it easier for doctors and patients to work together to personalize medical care to the patient’s specific needs and preferences.

Sutter Health chief research officer Dr Walter Buzz Stewart said: "We believe that innovative technologies can help us develop a deeper understanding of patient needs, values, and care preferences — and create more time during office visits for doctors and patients to partner toward improved health outcomes."

The partnership will result in the development of an electronic data collection system to collect information directly from the patient, as well as technological means for integrating clinical and patient reported data in an engaging visual display.

The firms will also focus on developing visual displays and other technologies that help connect patients and healthcare professionals and create more personal care, allowing to improve shared decision making.